Rituximab zur Behandlung von Epidermolysis bullosa acquisita: Eine große Fallserie mit 15 Patienten.

Dasdar, Shayan; Kianfar, Nika; Tavakolpour, Soheil; Balighi, Kamran; Mahmoudi, Hamidreza; Daneshpazhooh, Maryam

Dasdar, Shayan; Kianfar, Nika; Tavakolpour, Soheil; Balighi, Kamran; Mahmoudi, Hamidreza; Daneshpazhooh, Maryam.

Afiliação

Dasdar S; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Kianfar N; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Tavakolpour S; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Balighi K; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Mahmoudi H; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Daneshpazhooh M; Autoimmune Bullous Diseases Research Center, Tehran University of Medical Sciences, Tehran, Iran.

J Dtsch Dermatol Ges ; 21(7): 779-784, 2023 07.

Article em De | MEDLINE | ID: mdl-37427724

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: De Revista: J Dtsch Dermatol Ges Assunto da revista: DERMATOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Irã

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google